XML 59 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity-based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense Stock‑based compensation expense by classification within the consolidated statements of operations and comprehensive loss is as follows (in thousands):

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Research and development

 

$

47,944

 

 

$

46,356

 

 

$

53,956

 

General and administrative

 

 

38,623

 

 

 

34,672

 

 

 

43,991

 

Total

 

$

86,567

 

 

$

81,028

 

 

$

97,947

 

Fair Value of Each Option Issued to Employees Estimated Using Black-Scholes Option-Pricing Model

The fair value of each option issued to employees was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Options granted

 

 

1,566,536

 

 

 

1,860,485

 

 

 

1,492,589

 

Weighted-average exercise price

 

$

62.40

 

 

$

45.47

 

 

$

60.19

 

Weighted-average grant date fair value

 

$

38.63

 

 

$

28.39

 

 

$

38.54

 

Assumptions:

 

 

 

 

 

 

 

 

 

Expected volatility

 

 

63.9

%

 

 

65.1

%

 

 

70.2

%

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

Risk-free interest rate

 

 

4.2

%

 

 

4.1

%

 

 

2.6

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Summary of Stock Option Activity

The following table summarizes stock option activity under the Company’s equity award plans (intrinsic value in thousands):

 

 

Shares

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2023

 

 

7,204,372

 

 

$

55.05

 

 

 

6.7

 

 

$

115,681

 

Granted

 

 

1,566,536

 

 

 

62.40

 

 

 

 

 

 

 

Exercised

 

 

(900,136

)

 

 

33.80

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(581,889

)

 

 

69.92

 

 

 

 

 

 

 

Outstanding at December 31, 2024

 

 

7,288,883

 

 

$

58.07

 

 

 

6.6

 

 

$

14,050

 

Exercisable at December 31, 2024

 

 

4,851,838

 

 

$

58.64

 

 

 

5.5

 

 

$

14,050

 

Vested and expected to vest at December 31, 2024

 

 

7,288,883

 

 

$

58.07

 

 

 

6.6

 

 

$

14,050

 

Summary of Restricted Stock Activity

The following table summarizes the restricted stock unit activity under the Company’s equity award plans:

 

 

Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

Unvested balance at December 31, 2023

 

 

1,781,415

 

 

$

61.00

 

Granted

 

 

1,284,894

 

 

 

60.26

 

Vested

 

 

(450,701

)

 

 

70.13

 

Cancelled or forfeited

 

 

(217,965

)

 

 

57.41

 

Unvested balance at December 31, 2024

 

 

2,397,643

 

 

$

59.21